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The skeletal muscle Ca21 release channel/ryanodine
receptor (RyR1) is a prototypic redox-responsive ion
channel. Nearly half of the 101 cysteines per RyR1 sub-
unit are kept in a reduced (free thiol) state under con-
ditions comparable with resting muscle. Here we as-
sessed the effects of physiological determinants of
cellular redox state (oxygen tension, reduced (GSH) or
oxidized (GSSG) glutathione, and NO/O2
. (released by
3-morpholinosydnonimine)) on RyR1 redox state and ac-
tivity. Oxidation of ;10 RyR1 thiols (from ;48 to ;38
thiols/RyR1 subunit) had little effect on channel activ-
ity. Channel activity increased reversibly as the number
of thiols was further reduced to ;23/subunit, whereas
more extensive oxidation (to ;13 thiols/subunit) inacti-
vated the channel irreversibly. Neither S-nitrosylation
nor tyrosine nitration contributed to these effects. The
results identify at least three functional classes of RyR1
thiols and suggest that 1) the channel may be protected
from oxidation by a large reservoir of functionally inert
thiols, 2) the channel may be designed to respond to
moderate oxidative stress by a change in activation set-
point, and 3) the channel is susceptible to oxidative in-
jury under more extensive conditions.
Ca21 release channels/ryanodine receptors (RyRs)1 are the
largest known ion channels, consisting of four ;565-kDa RyR
subunits and four associated 12-kDa FK506-binding protein
subunits (1, 2). Following an action potential, the cardiac and
skeletal muscle RyR isoforms release Ca21 from an intracellu-
lar Ca21 storing membrane compartment, the sarcoplasmic
reticulum (SR), in a process known as excitation-contraction
coupling. Numerous endogenous effectors are known to regu-
late RyR function and therefore muscle contractility. These
effectors range from ions (Ca21 and Mg21) to other small mol-
ecules (adenine nucleotides) to polypeptides such as calmodulin
(1, 2). Recent work has also established RyRs as prototypic
redox-sensitive ion channels. The skeletal muscle isoform of
RyR (RyR1) contains a large number of free thiols: as many as
50 out of a total of 101 cysteine residues/subunit (100 cysteines/
RyR1 subunit (3) and 1 cysteine/FK506-binding protein sub-
unit (4)) (5). RyR1 channel activity is dramatically altered by
redox modifications of critical thiols (oxidation, S-nitrosylation,
or alkylation) (5–14). Conversely, RyR1 has thiols whose redox
potential is dependent on effectors that regulate RyR1 activity
such as Ca21 and Mg21 (15). In a physiological context, nitric
oxide (NO) and reactive oxygen species are produced in con-
tracting muscle and have been shown to modulate in vitro RyR
redox state and channel activity (5, 12, 16–21). Remarkably,
RyR1 redox state and function are dependent on O2 tension (5).
Altering O2 tension alone dynamically reduced/oxidized as
many as 6–8 thiols/RyR1 subunit and thereby modified chan-
nel responsiveness to physiological concentrations of NO (5).
In this study, we varied reducing and oxidizing conditions to
explore in detail the effect of RyR1 redox state on channel
function. At one end of the redox spectrum, RyR1 was main-
tained in a highly reduced state by GSH at low pO2 (;10 mm
Hg). At the other end of the spectrum, we tested the effects of
the strongly oxidizing conditions produced by high concentra-
tions of NO/O2
. (released by 3-morpholinosydnonimine SIN-1).
Our studies demonstrate that 1) RyR1 thiols can be grouped
into at least three distinct functional classes, 2) RyR1 channel
function peaks in moderately oxidizing conditions (;23 free
thiols/RyR1 subunit), 3) channel closure is favored by strongly
reducing ($38 free thiols/RyR1 subunit) or oxidizing (#15 free
thiols/RyR1 subunit) conditions, and 4) NO and O2
., which are
produced in vivo (17), have concentration-dependent effects on
channel function that are mediated by thiol oxidation and may
have both physiological and pathological relevance.
EXPERIMENTAL PROCEDURES
Materials—[3H]Ryanodine was obtained from PerkinElmer Life Sci-
ences; unlabeled ryanodine and monobromobimane (mBB) from Calbio-
chem; SIN-1 from Molecular Probes, Inc. (Eugene, OR); and CHAPS,
leupeptin, and Pefabloc (a protease inhibitor) from Roche Molecular
Biochemicals. All other chemicals were of analytical grade.
Preparation of SR Vesicles—“Heavy” rabbit skeletal muscle SR mem-
brane fractions enriched in [3H]ryanodine binding, and Ca21 release
channel activities were prepared in the presence of protease inhibitors
(100 nM aprotinin, 1 mM leupeptin, 1 mM pepstatin, 1 mM benzamidine,
0.2 mM phenylmethylsulfonyl fluoride) as described (22).
Quantification of RyR1 Thiol and S-Nitrosothiol Contents—The
number of free thiols in RyR1 was determined as described previously
(5). Briefly, skeletal SR vesicles, treated with or without SIN-1 in the
absence or presence of GSH or GSSG at pO2 of ;10 or 150 mm Hg, were
centrifuged (100,000 3 g) at 4 °C for 1 h. The pellets were washed and
resuspended and then probed with an excess (500 mM) of the lipophilic,
thiol-specific agent mBB for 1 h in the dark at 24 °C. Following mBB
treatment, SR vesicles were solubilized with 1.5% CHAPS, and the
bimane-labeled RyR1 was isolated by sucrose density gradient centrif-
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ugation. The fluorescence intensity of bimane (i.e. the thiol content) in
the sucrose gradient fraction most enriched in RyR1 (.95% purity) was
determined and normalized for protein concentration as described (5).
The S-nitrosothiol content of RyR1 was determined by isolating the
receptor without prior mBB treatment and using a photolysis/chemilu-
minescence method (5, 12).
[3H]Ryanodine Binding—Unless otherwise indicated, skeletal SR
vesicles, treated with various concentrations of SIN-1 in the absence or
presence of GSH or GSSG at pO2 of ;10 or 150 mm Hg, were incubated
with 5 nM [3H]ryanodine at 24 °C in media containing 0.125 M KCl, 20
mM imidazole, pH 7.0, 0.3 mM Pefabloc, 30 mM leupeptin, and the
indicated concentrations of free Ca21. Nonspecific binding was deter-
mined using a 1000-fold excess of unlabeled ryanodine. After 5 h,
aliquots of the samples were diluted with 20 volumes of ice-cold water
and placed on Whatman GF/B filters soaked with 2% (w/w) polyethyl-
eneimine. Filters were washed with three 5-ml volumes of ice-cold
buffer, and the radioactivity remaining on the filters was determined by
liquid scintillation counting to obtain bound [3H]ryanodine.
Single Channel Recordings—Single channel measurements were
performed by fusing skeletal SR vesicles with Mueller-Rudin type bi-
layers containing phosphatidylethanolamine, phosphatidylserine, and
phosphatidylcholine in the ratio 5:3:2 (25 mg of total phospholipid/ml
n-decane) (5). The side of the bilayer to which the SR vesicles were
added was defined as the cis (cytoplasmic) side. The trans (SR luminal)
side of the bilayer was defined as ground. Single channels were re-
corded in a symmetric CsCH3SO3 buffer solution (0.25 M CsCH3SO3, 10
mM Cs-HEPES, pH 7.3) containing the additions indicated (see Fig. 4).
Measurement of the sensitivity of the channels to cytosolic Ca21 indi-
cated that in a majority of recordings (.98%) the cytosolic side of the
RyRs faced the cis side, and the luminal side faced the trans side of the
bilayer. Electrical signals were filtered at 2 kHz, digitized at 10 kHz,
and analyzed. Data acquisition and analysis were performed with a
commercially available software package (pClamp 6.0.4; Axon Instru-
ments, Burlingame, CA) with an IBM-compatible Pentium II computer
and 12-bit A/D to D/A converter (Digidata 1200, Axon Instruments).
Immunoblotting—RyR1 and nitrotyrosine contents of SR vesicles
were determined by immunoblot analysis. Samples were solubilized in
nonreducing sample buffer, containing 62.5 mM Tris-HCl, pH 6.8, 20%
glycerol (w/v), 1.2% SDS, and 0.05% bromphenol blue, and loaded onto
3–15% SDS-PAGE gradient gels. After electrophoresis, the proteins
were transferred overnight to a nitrocellulose membrane (Schleicher
and Schuell). The transferred membrane was blocked in Tris-buffered
saline buffer, containing 0.05% Tween 20, 20 mM Tris-HCl, pH 7.4, 250
mM NaCl, and 5% nonfat milk, with agitation for 2 h at room temper-
ature. RyR1 and nitrotyrosine proteins were identified using D110
anti-RyR1 monoclonal antibody (23) and anti-nitrotyrosine polyclonal
antibody (Upstate Biotechnology, Inc., Lake Placid, NY), respectively.
Secondary goat anti-mouse and anti-rabbit IgG-horseradish peroxi-
dase-linked antibodies were used at 1:2000 dilution. Color development
was accomplished using the DAB substrate kit (Roche Molecular
Biochemicals).
Other Biochemical Assays—Free Ca21 concentrations were obtained
by including in the solutions the appropriate amounts of Ca21 and
EGTA as determined using the stability constants and computer pro-
gram published by Shoenmakers et al. (24). Free Ca21 concentrations
.1 mM were verified with the use of a Ca21-selective electrode (World
Precision Instruments, Inc.). The protein concentrations were deter-
mined by the Amido Black method (25).
Ca21-ATPase activity in SR vesicles was assayed by malachite green
ATPase method (26) in the presence of a Ca21 ionophore (1 mM ionomy-
cin) and the absence or presence of SIN-1. Mg21-ATPase remaining in
the SR preparations was subtracted from the total ATPase by adding 1
mM EGTA to assay media.
Data Analysis—Results are given as means 6 S.D. with the number
of experiments in parentheses. Significance of differences of data was
analyzed with Student’s t test. Differences were regarded to be statis-
tically significant at p , 0.05 (*) and p , 0.01 (**).
RESULTS
Correlation of RyR1 Redox State and Activity—The highly
specific plant alkaloid ryanodine is widely used as a probe of
RyR channel activity because of its preferential binding to open
channel states (1, 2). In Fig. 1, [3H]ryanodine binding to rabbit
skeletal muscle SR vesicles, and therefore RyR1 channel activ-
ity, was determined as a function of three different redox mod-
ifiers: glutathione (5 mM GSH versus 5 mM GSSG), SIN-1
(which releases NO/O2
. (27, 28) (0–1.0 mM)), and O2 tension
(pO2 ;10 versus ;150 mm Hg). Comparison of the upper and
lower panels in Fig. 1 indicates that, in the absence of SIN-1
and glutathione, skeletal SR [3H]ryanodine binding is signifi-
cantly higher (p , 0.05) when measured in ambient pO2 (;150
mm Hg) than in muscle pO2 (10 mm Hg; Refs. 29 and 30). In
both conditions, GSH (triangles) reduced [3H]ryanodine bind-
ing as compared with the controls without glutathione (circles),
whereas GSSG (squares) increased [3H]ryanodine with the
highest level observed in ambient air. These results confirm
previous studies showing that reducing conditions (low O2 ten-
sion and GSH) promote RyR1 channel closure, and oxidizing
conditions (high oxygen tension and GSSG) favor channel open-
ing (5, 9, 15).
The effects of SIN-1 on RyR1 activity were dependent on
oxygen tension and the presence of GSH or GSSG. In ambient
O2 tension and the absence of glutathione, SIN-1 activated
RyR1 channel activity maximally at 0.2 mM. Higher concentra-
tions of SIN-1 reduced [3H]ryanodine binding ultimately back
to base line (Fig. 1B). The biphasic concentration dependence
indicates that moderate amounts of NO/O2
. activate RyR1,
whereas excess amounts are probably damaging. Although 0.2
mM SIN-1 also maximally activated the channel at a pO2 of 10
mm Hg, simulating physiological conditions in vivo (29, 30),
channel activity did not return to base line at 1.0 mM SIN-1
(Fig. 1A). The less pronounced effects of SIN-1 in muscle O2
tension can be explained by the fact that the rate of release of
NO and O2
. from SIN-1 is dependent on molecular oxygen
concentration (27, 28). In the added presence of 5 mM GSSG,
SIN-1 dose-dependently inactivated the channel in ambient
FIG. 1. Dose-dependent effects of SIN-1 on RyR1 channel ac-
tivity in low and high O2 tension. Effects of SIN-1 on specific
[3H]ryanodine binding to skeletal SR vesicles were determined either in
the absence (circles) or presence of 5 mM GSH (triangles) or GSSG
(squares) as described under “Experimental Procedures.” A, pO2 ;10
mm Hg; B, pO2 ;150 mm Hg. Compared with each control, asterisks
represent p , 0.05, and double asterisks represent p , 0.01.
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oxygen tension (Fig. 1B) but had only moderate effects at pO2
;10 mm Hg (Fig. 1A). Finally, in the presence of 5 mM GSH,
SIN-1 effects on [3H]ryanodine binding were almost entirely
suppressed. This latter observation is consistent with GSH
being a potent scavenger for reactive nitrogen and oxygen
species (31).
Recent studies have indicated that oxidation and S-nitrosy-
lation affect channel activity by altering RyR1’s interaction
with calmodulin (5, 13). SR vesicles contain 0.10–0.15 calmod-
ulin/RyR1 subunit (5). To eliminate the effects of endogenous
calmodulin, SR vesicles were pretreated with 2 mM myosin light
chain kinase-derived calmodulin binding peptide, followed by
centrifugation through a layer of 0.3 M sucrose to remove com-
plexed calmodulin and calmodulin binding peptide. After cen-
trifugation, the endogenous SR-associated calmodulin content
was reduced to ;5% of the control value, as determined by a
phosphodiesterase activation assay (5). The effects of SIN-1 on
RyR1 activity, as measured by [3H]ryanodine binding under
the conditions in Fig. 1, were then studied by exposing control
and pretreated vesicles to 0, 0.2, and 1.0 mM SIN-1 at pO2 ;150
mm Hg. An essentially identical activation by 0.2 mM SIN-1
and inactivation by 1.0 mM SIN-1 for vesicles pretreated and
not pretreated with the calmodulin binding peptide (data not
shown) indicated that SIN-1 did not transduce its effects in Fig.
1 via the small amounts of calmodulin associated with the SR
vesicles.
The oxidation or reduction of a large number of thiols is the
principle mechanism by which O2 tension and reducing agents
such as glutathione modulate RyR1 channel activity in SR
vesicles. A specific free thiol-labeling agent, mBB, was used to
correlate RyR1 free thiol content and activities in the presence
of redox active molecules. As reported previously (5), RyR1 in
SR vesicles exposed to 5 mM GSH had ;48 and ;40 free
thiols/subunit at pO2 ;10 or ;150 mm Hg, respectively. Expo-
sure of the vesicles to variable glutathione, O2, and/or NO/O2
.
concentrations resulted in the oxidation of up to 35 thiols/RyR1
subunit. A plot of [3H]ryanodine binding against the number of
free thiols per subunit revealed three principle redox states of
the channel (Fig. 2): state 1 involving oxidation of ;10 thiols
(;48 to ;38 thiols/RyR1 subunit), which had little effect on
channel activity; state 2 corresponding to the total loss of ;25
thiols (38–23 thiols/RyR1 subunit), which maximally activated
the channel; and state 3 corresponding to the oxidation of an
additional ;10 thiols (23–13 thiols/RyR1 subunit), which de-
creased [3H]ryanodine binding to levels observed under
strongly reducing conditions. Thus, RyR1 channel activity can
be variably affected by the oxidation of an enormous number of
thiols, ;35/subunit or 140/RyR1 tetramer.
Ca21 Dependence of Redox Modulation of RyR1 by
SIN-1/(NO/O
2
.)—The regulation of the RyR1 by Ca21, as
measured by [3H]ryanodine binding, was determined at the
three function-linked redox states of the channel corresponding
to ;30 (control), 23 (0.2 mM SIN-1), and 13 (1.0 mM SIN-1)
residual thiols/RyR1 subunit (studies done in ambient O2 ten-
sion, Fig. 2). Moderate oxidation by 0.2 mM SIN-1 activated the
RyR1 across the whole range of Ca21 concentrations (from pCa
8 to pCa 2; Fig. 3) with a greater degree of activation observed
at low Ca21 concentrations (pCa # 7). Extensive oxidation by
1.0 mM SIN-1 resulted in reduced [3H]ryanodine binding and a
broadened Ca21 activation/inactivation profile. These results
suggest that SIN-1 activates and inactivates the RyR1, altering
the Ca21 dependence of channel activity.
The effects of SIN-1 on RyR1 activity were also explored in
single channel measurements using maximally activating con-
centrations of Ca21 (10 mM; Fig. 3) and SIN-1 (0.2 mM; Fig. 1).
Skeletal SR vesicles were incorporated into planar lipid bilay-
ers, and RyR1 single channel activity was recorded at ambient
oxygen tension with Cs1 as the current carrier to eliminate
other ion currents also present in SR vesicles (32). In the
FIG. 2. RyR1 channel activity is controlled by redox state.
[3H]Ryanodine binding and free thiol content were determined as de-
scribed under “Experimental Procedures” either in the absence (circles)
or presence of 5 mM GSH (squares) or GSSG (triangles) in either pO2
;10 mm Hg (symbols without cross) or ;150 mm Hg (symbols with
cross) and in the absence (open symbols) or presence of 0.2 mM (gray
symbols) or 1 mM (dark symbols) SIN-1. [3H]Ryanodine binding was
determined by incubating SR vesicles for 1 h at 24 °C with 25 nM
[3H]ryanodine in medium containing 0.125 M KCl, 20 mM imidazole, pH
7.0, 0.3 mM Pefabloc, 30 mM leupeptin, and 10 mM free Ca21. The free
thiol content of RyR1 was determined by the mBB fluorescence method
in the same conditions. Data are the averages of at least three experi-
ments done in duplicate with the S.D. being less than 20% for the
[3H]ryanodine binding and less than 15% for the free thiol content
determinations.
FIG. 3. Effects of SIN-1 on Ca21 dependence of [3H]ryanodine
binding to SR vesicles. Vesicles were incubated for 30 min at 24 °C
with either 0, 0.2, or 1.0 mM SIN-1 and then incubated for 5 h with 5 nM
[3H]ryanodine at the indicated Ca21 concentrations. Data are the
means 6 S.D. of three experiments.
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presence of an optimally activating Ca21 concentration of 10
mM, channel open probability (Po) increased 2–3-fold (n 5 6)
after the addition of 0.2 mM SIN-1 to the cytosolic (cis) chamber
of the bilayer apparatus (Fig. 4). Thus, in agreement with the
[3H]ryanodine binding measurements, single channel record-
ings show that a moderately oxidizing concentration of SIN-1
activates the RyR1.
Mechanism of Redox Modification of RyR1 by SIN-1/
(NO/O2
.)—In the presence of molecular oxygen, SIN-1 gener-
ates one molecule each of NO and O2
., which probably combine
rapidly (rate constant of 3.7 3 107 M21 s21) to form peroxyni-
trite (27, 28). Therefore, peroxynitrite is probably a dominant
oxidative species in experiments involving SIN-1. Rapid forma-
tion of peroxynitrite was supported by the finding that a NO
electrode with a high sensitivity (5) failed to detect any NO
release from SIN-1 in our assay conditions at either oxygen
tension (data not shown).
Peroxynitrite oxidizes thiols reversibly to disulfide bonds or
sulfenic (SOH) acids or irreversibly to sulfinic (SO2H) or sul-
fonic acids (SO3H) (33–35). The reversibility of RyR1 oxidation
was determined at ambient oxygen tension from the thiol con-
tent of SR vesicles that were first treated with 0, 0.2, or 1.0 mM
SIN-1 at 24 °C for 5 h and then exposed to 5 mM GSH (exper-
imental group) or no reducing equivalent (control) for another
5 h. [3H]Ryanodine binding and free RyR1 thiol content were
determined after the final 5 h of incubation. The results are
summarized in Fig. 5, with the number of free thiols per RyR1
subunit (mean 6 S.D., n $ 3) labeled at the top of each column.
Channel activation and thiol oxidation by 0.2 mM SIN-1 were
nearly completely reversed by 5 mM GSH. In contrast, 5 mM
GSH could not reverse the effects of 1.0 mM SIN-1 on RyR1
channel activity or redox state (Fig. 5, third pair of columns).
These results suggest, but do not prove, that at high concen-
trations of peroxynitrite, numerous RyR1 thiols (;10/RyR1
subunit) proceeded to high degrees of oxidation.
Peroxynitrite may also S-nitrosylate free thiols in proteins
(33, 34). We have shown previously that S-nitrosylation of a
single thiol per RyR1 can activate the channel (5). To see if
RyR1 is S-nitrosylated by SIN-1, control and SIN-1 (0.2 mM)-
treated samples were assayed for S-nitrosothiol content using a
photolysis/chemiluminescence method (5, 12). In the control
group, there were ;0.4 S-nitrosothiol/RyR1 subunits, a level
comparable with the endogenous amount of S-nitrosylation
found in our previous study (5). SIN-1/peroxynitrite did not
S-nitrosylate any additional RyR1 thiols (Table I). Therefore,
unlike NO (5), SIN-1/peroxynitrite did not activate RyR1 by
S-nitrosylation.
Peroxynitrite can also modify proteins by the addition of a
nitro group to the ortho position of tyrosine to form nitroty-
rosine (33, 34). In the case of the SR Ca21-ATPase, in vitro
exposure of skeletal SR vesicles to peroxynitrite resulted in
both S-nitrosylation (36) and nitrotyrosine formation (37). Both
modifications contributed to inhibition of SR Ca21-ATPase ac-
tivity. Nitrotyrosine formation could therefore represent an
additional mechanism by which SIN-1 modulates RyR1, and
this possibility was examined in immunoblots. A polyclonal
antibody recognizing nitrotyrosine (Fig. 6A, lanes 4–6) did not
detect any nitrotyrosine formation in the region of the blots
corresponding to RyR1 (Fig. 6A, lanes 1–3) in controls and SR
vesicles exposed to 0.2 or 1.0 mM SIN-1. In contrast, the anti-
nitrotyrosine antibody revealed a weak band in the control
sample (lane 4) and two stronger bands in the samples treated
with 0.2 mM SIN-1 (lane 5) and 1.0 mM SIN-1 (lane 6), corre-
sponding to a protein with an apparent molecular mass of ;100
FIG. 4. Effect of SIN-1 on RyR1 single channel activities. Skel-
etal SR vesicles were fused with lipid bilayers at pO2 ; 150 mm Hg. A,
single RyR1 channel currents, shown as downward deflections from
closed (c) levels, were recorded in symmetrical 0.25 M CsCH3SO3, pH 7.3
buffer at a holding potential of 235 mV. Top trace, control with 10 mM
free Ca21, Po 5 0.08; second trace, immediately after the addition of 0.2
mM SIN-1 to the cytosolic side of the bilayer, Po 5 0.16. B, quantitative
presentation of changes in Po. Values of controls were normalized as
100%, and the changes were expressed as percentage of the controls.
Normalized Po before (open columns) and after the addition (filled
columns) of 0.2 mM SIN-1 (n 5 6) is shown. Data are the means 6 S.D.
of six experiments. Compared with control, asterisks represent p , 0.05.
FIG. 5. Reversibility of SIN-1 induced changes in RyR1 chan-
nel activity and free thiol content. SR vesicles were treated for 5 h
at 24 °C at pO2 ;150 mm Hg with 0, 0.2, or 1.0 mM SIN-1 and then
incubated for another 5 h in the absence (open columns) or presence of
5 mM GSH (filled columns) either in the absence (free thiol quantifica-
tion) or presence of 5 nM [3H]ryanodine ([3H]ryanodine binding). The
free thiol content (thiols per RyR1 subunit) is given above the columns.
Data are the means 6 S.D. of at least three experiments.
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kDa. The results suggested that a 100-kDa protein such as the
skeletal muscle SR Ca21-ATPase has endogenous nitroty-
rosine(s) and that its level is increased by exogenous SIN-1/
peroxynitrite (37). In favor of this interpretation, SIN-1 (0.2 or
1.0 mM) inhibited SR Ca21-ATPase activity by about ;30 and
50%, respectively (Fig. 6B).
Taken together, the results suggest that SIN-1 acts in our
assay conditions as an oxidant rather than a NO donor. In the
absence of glutathione, NO/O2
. reversibly activates RyR1 at low
concentrations and irreversibly inactivates the channel at high
concentrations. Furthermore, modulation of RyR1 by NO/O2
.
appears to be due to oxidation of thiols, since neither S-nitrosy-
lation nor tyrosine nitration of RyR1 was detected.
DISCUSSION
Contracting muscle produces reactive oxygen and nitrogen
species (16, 17, 38, 39). A functional role of these molecules is
indicated by the finding that force development in muscle is
affected using nitric-oxide synthase inhibitors and scavengers
of superoxide. The data we have presented here imply that the
effects of NO/O2
.-related species are mediated, at least in part,
through the SR Ca21 release channel in skeletal muscle.
The RyR1 is exquisitely sensitive to redox modulation. Am-
ple evidence indicates that RyRs are activated or inactivated or
both by sulfhydryl-modifying molecules (5–15, 18–21, 40, 41).
We previously uncovered a striking plasticity of redox state in
RyR1 channel activity (5). RyR1 free thiol content and channel
activity were dynamically controlled by GSH/GSSG, oxygen
tension, and NO. Other recent studies have shown that RyR1
responds to changes in transmembrane glutathione redox poten-
tial (14) and contains thiols whose redox potential is dependent
on ligands (Ca21, Mg21) that control RyR1 activity (15).
In this study, we used SIN-1 to probe the effect of redox state
on RyR1 activity and have done so under a spectrum of redox
conditions that are encountered in muscle, by further varying
GSH/GSSG and pO2. SIN-1 spontaneously generates NO and
O2
. (27), both of which rapidly combine in a 1:1 stoichiometry to
form the highly oxidative species peroxynitrite, although
NO/O2
. chemistry may produce other species as well (28, 33).
While NO and O2
. are modulators of muscle contractility (16,
17, 38–40), we consider it unlikely that NO reacted with the
RyR1, since we were unable to detect it with a NO electrode.
Furthermore, SIN-1 and free NO modulate the skeletal muscle
Ca21 release channel by two very different redox-related mech-
anisms. NO activates the channel at pO2 ;10 mm Hg by
S-nitrosylation of a single cysteine per RyR1 subunit (5),
whereas SIN-1 affected channel activity by the oxidation of a
large number of thiols. NO/O2
. generation is likely to be encoun-
tered in normally functioning muscle and in pathological
states. Indeed, immunoblotting with an anti-nitrotyrosine an-
tibody revealed endogenous and SIN-1-mediated nitration in a
protein that co-migrated with the SR Ca21-ATPase, confirming
a previous report (37). Notably, the anti-nitrotyrosine antibody
failed to detect endogenous or SIN-1-mediated nitration of ty-
rosines in RyR1.
Exposure to the three redox variables O2, glutathione, and
SIN-1 revealed three distinct redox states of RyR1. The free
thiol content ranged from as low as 13 to as high as 48 thiols/
RyR1 subunit (SH/RyR1s) (see scheme below).
Moderate oxidation Extensive oxidation
low reversible irreversible
RyR1 activity N RyR1 activation f RyR1 inactivation
(;48–38 SH/RyR1s) (;35–23 SH/RyR1s) (;21–13 SH/RyR1s)
SCHEME 1
RyR1 free thiol content was high and channel activity was low
in the presence of 5 mM GSH at pO2 ;10 mm Hg; i.e. there are
;48 free thiols/RyR1 subunit under conditions encountered in
normally functioning skeletal muscle. Remarkably, oxidation
of ;10 free thiols/RyR1 subunit (SIN-1 in the presence of 5 mM
GSH) had virtually no effect on RyR1 activity, suggesting that
RyR1 has a large buffer capacity against oxidants such as O2
. or
peroxynitrite. In addition, these thiols probably subserve the
O2 sensor function that tunes the NO response in muscle (5).
Moderate oxidative activation (5 mM GSSG, 0.2 mM SIN-1 in
the absence of 5 mM GSH) was accounted for by the loss of ;15
extra thiols and was reversible. Thus, RyR1 can probably re-
spond to moderate changes in cellular redox state with changes
in basal setpoint (i.e. a change in activity is maintained across
TABLE I
SNO/RyR1 and [3H]ryanodine binding with or without SIN-1
The amounts of S-nitrosothiols (SNO) of RyR1 were assayed by the
photolysis/chemiluminescence method described under “Experimental
Procedures.” [3H]Ryanodine binding was determined under the same
conditions (with 10 mM free Ca21). Data are the means 6 S.D. of the
number of experiments given in parentheses.
Preparations SNO/RyR1 subunit Bound [3H]ryanodine
pmol/mg protein
Control 0.41 6 0.02 (6) 0.49 6 0.10 (7)
1 5 mM GSH 0.09 6 0.05 (4) 0.25 6 0.04 (4)
SIN-1 (0.2 mM) 0.39 6 0.10 (5) 1.41 6 0.16 (7)
1 5 mM GSH 0.23 6 0.07 (5) 0.35 6 0.04 (3)
FIG. 6. Immunoblots and Ca21-ATPase activity of SR vesicles
treated with SIN-1. A, SR vesicles were incubated for 1 h at 24 °C
either in the absence (lanes 1 and 4) or presence of 0.2 mM (lanes 2 and
5) or 1.0 mM (lanes 3 and 6) SIN-1. Proteins separated by 3–15%
gradient SDS-PAGE were transferred to nitrocellulose membranes and
probed with an anti-RyR1 (lanes 1–3) or anti-nitrotyrosine (lanes 4–6)
antibody. The anti-nitrotyrosine antibody did not detect nitrotyrosines
in RyR1. However, a protein with a molecular mass of ;100 kDa was
recognized by the antibody, and SIN-1 significantly increased the level
of nitrotyrosines. B, SIN-1 (0.2 or 1.0 mM) significantly decreased SR
Ca21-ATPase activity. Data are the means 6 S.D. of three experiments.
Compared with control, double asterisks represent p , 0.01.
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the whole Ca21 concentration range). Extensive oxidative in-
activation (1.0 mM SIN-1 in the absence and presence of 5 mM
GSSG) was attributed to the loss of up to 10 additional thiols
(;13 free thiols/RyR1 subunit remain) and was irreversible,
making it likely to be of pathological rather than physiological
significance. Therefore, RyR1 redox state and function appear
to be intimately linked.
This analysis of RyR1 is reminiscent of our previous studies
of RyR2 (12). In the case of RyR1, however, the oxidation of up
to 25 thiols was reversible (suggesting the formation of disul-
fides and/or sulfenic acids), whereas only 5–6 thiols could be
oxidized in the cardiac channel before irreversible changes
were encountered. Irreversible thiol oxidation (suggesting oxi-
dation to sulfinic or sulfonic acids) was dependent on the con-
centration of the oxidant (1.0 mM SIN-1) and required the
absence of GSH. Although the (patho)physiological correlative
of thiol oxidation remains to be elucidated, the finding of en-
dogenous nitration in the SR (Ref. 37 and this study) indicates
that such oxidative modifications are likely (i.e. thiols are gen-
erally more reactive toward NO/O2
. and peroxynitrite than ty-
rosines (42)).
Intracellular Ca21 concentration, the main determinant of
skeletal muscle contractile function, is controlled by the RyR1
and an ATP-driven Ca21 pump, with the former releasing the
stored Ca21 from SR to initiate contraction and the later se-
questering Ca21 back in SR to initiate relaxation. We previ-
ously showed that O2 tension dynamically reduced/oxidized
6–8 thiols/RyR1 subunit. The alteration of channel redox state
determined its responsiveness to S-nitrosylation by NO of one
cysteine per RyR1 subunit, and the effect of S-nitrosylation on
channel activity was transduced via calmodulin (5). We believe
that such regulation may impact on excitation-contraction cou-
pling. On the other hand, we now show that NO/O2
. can trans-
duce its effects on RyR1 independently of calmodulin, thus
providing an additional means by which the redox state of the
cell may influence RyR1 function. But these findings probably
bear on situations characterized by oxidative stress, where we
envision that the RyR1 would counter impairments of force
production imposed by oxidizing conditions with oxidation-in-
duced activation. Ultimately, however, irreversible oxidation of
RyR1 thiols may contribute to dysfunction of muscle. The rel-
evance of these findings to conditions such as in fatigue, spasm,
and rhabdomyolysis remains to be shown.
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12408–12415
37. Viner, R. I., Ferrington, D. A., Williams, T. D., Bigelow, D. J., and Schöneich,
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